The booming markets for GLP-1 drugs pose special challenges to pharmaceutical manufacturers. For this purpose, Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, has developed a new multifunctional label for pens and autoinjectors combining analogue and digital security features with additional benefits. Schreiner MediPharm will be presenting the label at CPHI Milan from 6-8 October 2026 at Booth 11F61.
Security for product, brand, and patient
The high demand for GLP-1 drugs to treat Type 2 diabetes and obesity makes them an increasingly attractive target for counterfeiting attempts. At the same time, the requirements concerning a safe and user-friendly design of pens and autoinjectors keep growing. Schreiner MediPharm’s new multifunctional label has been developed to satisfy these requirements and supports pharmaceutical manufacturers in strengthening product and patient safety along the entire supply chain.
Multi-level product authentication
The specialty label from Schreiner MediPharm integrates various analogue and digital security features for reliable authentication. Overt security features, such as ShiftSecure with its positive-negative effect depending on the viewing angle, can be verified directly by visual inspection. They are complemented by semi-covert features such as microtext and InfraredSecure, as well as digital functions like covert, smartphone-readable printed codes, or integrated NFC technology. They enable multi-level authentication for various stakeholders along the supply chain, from the pharmaceutical manufacturer to the patient. In addition, the digital features can be used for geo-tracking to improve detection and tracking of counterfeiting and grey market activities.
Tampering clearly detectable
A key element of the solution is the irreversible first-opening indication feature. Because the label covers part of the pen cap, any opening attempt becomes permanently visible. Optionally, this first-opening evidence can also be delivered digitally via NFC plus a smartphone. At the same time, the design prevents undetected recapping and illegal reuse of the label. The special label construction permanently protects all product information against abrasion. In an attempt to remove the label, parts of the printed layer will remain so that the pen cannot be reused illegally.
Convenience and brand visibility
In addition to the security functions, Schreiner MediPharm’s label improves the user-friendliness of the devices. Due to the extended label area, more space is available for product information, larger font, and customised design. The integration of an NFC chip opens up additional opportunities for digital services and interactive user support. The functional label is tailored to each customer’s requirements and complements existing platform devices of pen and autoinjector manufacturers by additional functions.
Efficient integration into existing production processes
Scalable production capacities at Schreiner MediPharm and the seamless integration of the labels into high-speed labelling processes support pharmaceutical manufacturers in assuring efficient and reliable supply, even in the event of growing demand. CPHI Milan 2026 visitors are going to receive insights into how integrated security and functional features combine product, brand, and patient protection while enhancing the ease of use of modern injection systems.